Veterinary Medicines

Program 80 mg Suspension for Injection for Cats

Authorised
  • Lufenuron
Download as PDF

Product identification

Medicine name:
Program 80 mg Suspension for Injection for Cats
Program 80 mg Suspension zur Injektion für Katzen
Active substance:
  • Lufenuron
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Lufenuron
    80.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53BC01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
Available in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Elanco France S.A.S
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00352
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0422/002
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • France
  • Germany
  • Luxembourg
  • Portugal
  • Spain

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 3/08/2023
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 3/08/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 3/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."